Zhejiang CONBA Pharmaceutical Co.,Ltd. (600572.SS)
CNY 4.77
(0.0%)
CNY 4.77
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 591.57 Million CNY | 65.19% |
| 2022 | 358.11 Million CNY | -82.25% |
| 2021 | 2.01 Billion CNY | 345.06% |
| 2020 | 453.3 Million CNY | 266.95% |
| 2019 | -271.51 Million CNY | -133.78% |
| 2018 | 803.79 Million CNY | 13.03% |
| 2017 | 711.11 Million CNY | 61.23% |
| 2016 | 441.06 Million CNY | 0.16% |
| 2015 | 440.37 Million CNY | -20.27% |
| 2014 | 552.34 Million CNY | 32.34% |
| 2013 | 417.36 Million CNY | 41.14% |
| 2012 | 295.71 Million CNY | 5.53% |
| 2011 | 280.22 Million CNY | 51.04% |
| 2010 | 185.52 Million CNY | 83.3% |
| 2009 | 101.21 Million CNY | 10.05% |
| 2008 | 91.97 Million CNY | -13.34% |
| 2007 | 106.13 Million CNY | 86.99% |
| 2006 | 56.75 Million CNY | 30.1% |
| 2005 | 43.62 Million CNY | 52.4% |
| 2004 | 28.62 Million CNY | -28.56% |
| 2003 | 40.07 Million CNY | -4.2% |
| 2002 | 41.82 Million CNY | -1.19% |
| 2001 | 42.32 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 166.13 Million CNY | -23.11% |
| 2024 Q1 | 216.06 Million CNY | 782.35% |
| 2024 Q3 | 136.25 Million CNY | -17.98% |
| 2023 Q3 | 107.1 Million CNY | -53.82% |
| 2023 Q4 | -31.66 Million CNY | -129.56% |
| 2023 Q1 | 284.2 Million CNY | 120.71% |
| 2023 FY | 591.57 Million CNY | 65.19% |
| 2023 Q2 | 231.92 Million CNY | -18.4% |
| 2022 Q1 | 103.28 Million CNY | -94.24% |
| 2022 FY | 358.11 Million CNY | -82.25% |
| 2022 Q2 | 107.31 Million CNY | 3.9% |
| 2022 Q3 | 48.13 Million CNY | -55.15% |
| 2022 Q4 | 128.76 Million CNY | 167.54% |
| 2021 Q1 | 47.83 Million CNY | 152.85% |
| 2021 Q3 | -30.91 Million CNY | -115.63% |
| 2021 Q4 | 1.79 Billion CNY | 5905.64% |
| 2021 FY | 2.01 Billion CNY | 345.06% |
| 2021 Q2 | 197.76 Million CNY | 313.41% |
| 2020 Q4 | -90.52 Million CNY | -249.94% |
| 2020 FY | 453.3 Million CNY | 266.95% |
| 2020 Q3 | 60.36 Million CNY | -79.95% |
| 2020 Q2 | 301.13 Million CNY | 65.18% |
| 2020 Q1 | 182.31 Million CNY | 122.23% |
| 2019 Q2 | 213.57 Million CNY | 19.72% |
| 2019 Q3 | 84.62 Million CNY | -60.38% |
| 2019 Q1 | 178.39 Million CNY | 380.19% |
| 2019 FY | -271.51 Million CNY | -133.78% |
| 2019 Q4 | -820.02 Million CNY | -1069.0% |
| 2018 Q2 | 280.59 Million CNY | 4.75% |
| 2018 FY | 803.79 Million CNY | 13.03% |
| 2018 Q4 | 37.15 Million CNY | -83.23% |
| 2018 Q1 | 267.88 Million CNY | 157.63% |
| 2018 Q3 | 221.53 Million CNY | -21.05% |
| 2017 FY | 711.11 Million CNY | 61.23% |
| 2017 Q4 | 103.97 Million CNY | -53.28% |
| 2017 Q3 | 222.57 Million CNY | 13.8% |
| 2017 Q2 | 195.58 Million CNY | 3.49% |
| 2017 Q1 | 188.98 Million CNY | 2167.06% |
| 2016 Q3 | 143.15 Million CNY | -6.97% |
| 2016 FY | 441.06 Million CNY | 0.16% |
| 2016 Q4 | -9.14 Million CNY | -106.39% |
| 2016 Q2 | 153.86 Million CNY | 0.44% |
| 2016 Q1 | 153.19 Million CNY | 187.58% |
| 2015 Q2 | 314.59 Million CNY | 151.27% |
| 2015 FY | 440.37 Million CNY | -20.27% |
| 2015 Q1 | 125.2 Million CNY | -19.29% |
| 2015 Q4 | -174.91 Million CNY | -199.68% |
| 2015 Q3 | 175.48 Million CNY | -44.22% |
| 2014 Q2 | 149.7 Million CNY | 8.09% |
| 2014 Q3 | 109.01 Million CNY | -27.18% |
| 2014 Q4 | 155.12 Million CNY | 42.29% |
| 2014 FY | 552.34 Million CNY | 32.34% |
| 2014 Q1 | 138.5 Million CNY | 23.38% |
| 2013 Q4 | 112.25 Million CNY | 13.75% |
| 2013 Q2 | 102.03 Million CNY | -2.27% |
| 2013 Q1 | 104.39 Million CNY | -11.42% |
| 2013 FY | 417.36 Million CNY | 41.14% |
| 2013 Q3 | 98.68 Million CNY | -3.28% |
| 2012 FY | 295.71 Million CNY | 5.53% |
| 2012 Q1 | 54.42 Million CNY | 10.91% |
| 2012 Q4 | 117.85 Million CNY | 122.57% |
| 2012 Q3 | 52.95 Million CNY | -35.09% |
| 2012 Q2 | 81.57 Million CNY | 49.9% |
| 2011 Q3 | 49.19 Million CNY | 2.67% |
| 2011 Q2 | 47.91 Million CNY | -58.54% |
| 2011 Q1 | 115.57 Million CNY | 108.81% |
| 2011 FY | 280.22 Million CNY | 51.04% |
| 2011 Q4 | 49.06 Million CNY | -0.27% |
| 2010 Q2 | 62.67 Million CNY | 81.56% |
| 2010 Q1 | 34.52 Million CNY | -8.54% |
| 2010 FY | 185.52 Million CNY | 83.3% |
| 2010 Q4 | 55.34 Million CNY | 46.83% |
| 2010 Q3 | 37.69 Million CNY | -39.85% |
| 2009 Q3 | 23.5 Million CNY | 14.9% |
| 2009 Q2 | 20.45 Million CNY | 4.86% |
| 2009 Q1 | 19.51 Million CNY | -32.44% |
| 2009 FY | 101.21 Million CNY | 10.05% |
| 2009 Q4 | 37.74 Million CNY | 60.57% |
| 2008 Q3 | 1.87 Million CNY | -94.97% |
| 2008 Q4 | 28.87 Million CNY | 1443.33% |
| 2008 FY | 91.97 Million CNY | -13.34% |
| 2008 Q1 | 24.03 Million CNY | -39.23% |
| 2008 Q2 | 37.18 Million CNY | 54.69% |
| 2007 Q2 | 14.64 Million CNY | -25.67% |
| 2007 Q1 | 19.7 Million CNY | -12.43% |
| 2007 FY | 106.13 Million CNY | 86.99% |
| 2007 Q3 | 28.27 Million CNY | 93.02% |
| 2007 Q4 | 39.55 Million CNY | 39.91% |
| 2006 Q1 | 14.32 Million CNY | -21.77% |
| 2006 Q2 | 5.68 Million CNY | -60.29% |
| 2006 Q3 | 15.12 Million CNY | 165.99% |
| 2006 Q4 | 22.5 Million CNY | 48.74% |
| 2006 FY | 56.75 Million CNY | 30.1% |
| 2005 Q1 | 12.13 Million CNY | 78.93% |
| 2005 Q4 | 18.31 Million CNY | 189.34% |
| 2005 Q3 | 6.32 Million CNY | -7.72% |
| 2005 FY | 43.62 Million CNY | 52.4% |
| 2005 Q2 | 6.85 Million CNY | -43.47% |
| 2004 FY | 28.62 Million CNY | -28.56% |
| 2004 Q1 | 12.02 Million CNY | -1.03% |
| 2004 Q2 | 2.73 Million CNY | -77.27% |
| 2004 Q3 | 7.08 Million CNY | 159.22% |
| 2004 Q4 | 6.77 Million CNY | -4.32% |
| 2003 Q4 | 12.15 Million CNY | -10.61% |
| 2003 Q3 | 13.59 Million CNY | 0.0% |
| 2003 FY | 40.07 Million CNY | -4.2% |
| 2002 FY | 41.82 Million CNY | -1.19% |
| 2001 FY | 42.32 Million CNY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Jiangsu Hengrui Medicine Co., Ltd. | 4.3 Billion CNY | 86.25% |
| Zhangzhou Pientzehuang Pharmaceutical., Ltd | 2.79 Billion CNY | 78.852% |
| Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. | 57 Million CNY | -937.835% |
| Aurora Optoelectronics Co.,Ltd. | -675.27 Million CNY | 187.604% |
| Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd | -38.27 Million CNY | 1645.58% |
| NanJing Pharmaceutical Company Limited | 577.82 Million CNY | -2.379% |
| GuangYuYuan Chinese Herbal Medicine Co., Ltd. | 90.07 Million CNY | -556.73% |
| Tonghua Dongbao Pharmaceutical Co., Ltd. | 1.16 Billion CNY | 49.344% |